MediciNova Inc (MNOV) stock
MNOVNasdaqPharmaceutical PreparationsFiscal year ends December 31
$1.31+0.04 (+3.15%)
Close on Nov 20, 2026Market cap $64.48MP/E –Yield –
MediciNova net income
Net income is the profit left for shareholders after every expense, interest and tax.
MediciNova's net income for the twelve months ending Jun 30, 2026 was -$10.75M. For fiscal 2025 it was -$12.00M. The highest annual figure on record is -$4.03M in fiscal 2013.
Annual net income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$12.00M | – |
| FY2024 | Dec 31, 2024 | -$11.05M | – |
| FY2023 | Dec 31, 2023 | -$8.57M | – |
| FY2022 | Dec 31, 2022 | -$14.07M | – |
| FY2021 | Dec 31, 2021 | -$10.13M | – |
| FY2020 | Dec 31, 2020 | -$13.85M | – |
| FY2019 | Dec 31, 2019 | -$12.94M | – |
| FY2018 | Dec 31, 2018 | -$14.68M | – |
| FY2017 | Dec 31, 2017 | -$11.16M | – |
| FY2016 | Dec 31, 2016 | -$10.87M | – |
| FY2015 | Dec 31, 2015 | -$8.85M | – |
| FY2014 | Dec 31, 2014 | -$9.20M | – |
| FY2013 | Dec 31, 2013 | -$4.03M | – |
| FY2012 | Dec 31, 2012 | -$10.96M | – |
| FY2011 | Dec 31, 2011 | -$17.73M | – |
| FY2010 | Dec 31, 2010 | -$20.19M | – |
| FY2009 | Dec 31, 2009 | -$20.37M | – |
| FY2008 | Dec 31, 2008 | -$21.92M | – |
| FY2007 | Dec 31, 2007 | -$48.90M | – |
| FY2006 | Dec 31, 2006 | -$35.69M | – |
| FY2005 | Dec 31, 2005 | -$25.69M | – |
Quarterly net income
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$2.31M | – |
| Q1 FY2026 | Mar 31, 2026 | -$2.59M | – |
| Q4 FY2025 | Dec 31, 2025 | -$2.80M | – |
| Q3 FY2025 | Sep 30, 2025 | -$3.05M | – |
| Q2 FY2025 | Jun 30, 2025 | -$3.28M | – |
| Q1 FY2025 | Mar 31, 2025 | -$2.86M | – |
| Q4 FY2024 | Dec 31, 2024 | -$2.81M | – |
| Q3 FY2024 | Sep 30, 2024 | -$2.85M | – |
| Q2 FY2024 | Jun 30, 2024 | -$2.63M | – |
| Q1 FY2024 | Mar 31, 2024 | -$2.75M | – |
| Q4 FY2023 | Dec 31, 2023 | -$2.06M | – |
| Q3 FY2023 | Sep 30, 2023 | -$723.11K | – |
| Q2 FY2023 | Jun 30, 2023 | -$2.87M | – |
| Q1 FY2023 | Mar 31, 2023 | -$2.92M | – |
| Q4 FY2022 | Dec 31, 2022 | -$3.00M | – |
| Q3 FY2022 | Sep 30, 2022 | -$3.65M | – |
| Q2 FY2022 | Jun 30, 2022 | -$4.03M | – |
| Q1 FY2022 | Mar 31, 2022 | -$3.39M | – |
| Q4 FY2021 | Dec 31, 2021 | -$2.08M | – |
| Q3 FY2021 | Sep 30, 2021 | -$3.58M | – |
| Q2 FY2021 | Jun 30, 2021 | -$4.28M | – |
| Q1 FY2021 | Mar 31, 2021 | -$187.80K | – |
| Q4 FY2020 | Dec 31, 2020 | -$2.99M | – |
| Q3 FY2020 | Sep 30, 2020 | -$3.70M | – |
| Q2 FY2020 | Jun 30, 2020 | -$4.45M | – |
| Q1 FY2020 | Mar 31, 2020 | -$2.71M | – |
| Q4 FY2019 | Dec 31, 2019 | -$1.98M | – |
| Q3 FY2019 | Sep 30, 2019 | -$2.38M | – |
| Q2 FY2019 | Jun 30, 2019 | -$3.88M | – |
| Q1 FY2019 | Mar 31, 2019 | -$4.70M | – |
| Q4 FY2018 | Dec 31, 2018 | -$208.00K | – |
| Q3 FY2018 | Sep 30, 2018 | -$6.78M | – |
| Q2 FY2018 | Jun 30, 2018 | -$3.14M | – |
| Q1 FY2018 | Mar 31, 2018 | -$4.54M | – |
| Q4 FY2017 | Dec 31, 2017 | -$1.60M | – |
| Q3 FY2017 | Sep 30, 2017 | -$3.76M | – |
| Q2 FY2017 | Jun 30, 2017 | -$2.79M | – |
| Q1 FY2017 | Mar 31, 2017 | -$3.02M | – |
| Q4 FY2016 | Dec 31, 2016 | -$1.45K | – |
| Q3 FY2016 | Sep 30, 2016 | -$2.84K | – |
See a number that looks wrong?